FI940469A0 - Kinoliinijohdannaisia immunostimulantteina - Google Patents
Kinoliinijohdannaisia immunostimulantteinaInfo
- Publication number
- FI940469A0 FI940469A0 FI940469A FI940469A FI940469A0 FI 940469 A0 FI940469 A0 FI 940469A0 FI 940469 A FI940469 A FI 940469A FI 940469 A FI940469 A FI 940469A FI 940469 A0 FI940469 A0 FI 940469A0
- Authority
- FI
- Finland
- Prior art keywords
- immunostimulants
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 229960001438 immunostimulant agent Drugs 0.000 title 1
- 239000003022 immunostimulating agent Substances 0.000 title 1
- 230000003308 immunostimulating effect Effects 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74082591A | 1991-08-02 | 1991-08-02 | |
| PCT/US1992/005435 WO1993003030A1 (en) | 1991-08-02 | 1992-07-01 | Quinoline derivatives as immunostimulants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI940469A0 true FI940469A0 (fi) | 1994-02-01 |
| FI940469A FI940469A (fi) | 1994-02-01 |
Family
ID=24978239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940469A FI940469A (fi) | 1991-08-02 | 1994-02-01 | Kinoliinijohdannaisia immunostimulantteina |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5506235A (pt) |
| EP (1) | EP0597003A1 (pt) |
| JP (1) | JPH06504294A (pt) |
| CA (1) | CA2114727C (pt) |
| FI (1) | FI940469A (pt) |
| IE (1) | IE922485A1 (pt) |
| PT (1) | PT100751A (pt) |
| WO (1) | WO1993003030A1 (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9510757D0 (en) * | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| DK0885198T3 (da) | 1996-03-05 | 2002-03-25 | Astrazeneca Ab | 4-Anilinoquinazolinderivater |
| ATE300521T1 (de) * | 1996-09-25 | 2005-08-15 | Astrazeneca Ab | Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern |
| US5919776A (en) * | 1996-12-20 | 1999-07-06 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
| GB9910579D0 (en) | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
| GB9910580D0 (en) | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
| IL151626A0 (en) | 2000-04-07 | 2003-04-10 | Astrazeneca Ab | Quinazoline compounds |
| AU2001295791A1 (en) | 2000-11-02 | 2002-05-15 | Astrazeneca Ab | 4-substituted quinolines as antitumor agents |
| AU2002210714A1 (en) | 2000-11-02 | 2002-06-11 | Astrazeneca Ab | Substituted quinolines as antitumor agents |
| SE0004056D0 (sv) * | 2000-11-06 | 2000-11-06 | Astrazeneca Ab | N-type calcium channel antagonists for the treatment of pain |
| GB0215823D0 (en) | 2002-07-09 | 2002-08-14 | Astrazeneca Ab | Quinazoline derivatives |
| GB0225579D0 (en) | 2002-11-02 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
| GEP20084572B (en) | 2003-12-23 | 2008-12-25 | Pfizer | Novel quinoline derivatives |
| DE102004063223A1 (de) * | 2004-12-22 | 2006-07-13 | Schering Ag | Chinolinderivat, dessen Verwendung, Herstellung und dieses enthaltendes Arzneimittel |
| WO2006066955A1 (de) * | 2004-12-22 | 2006-06-29 | Bayer Schering Pharma Aktiengesellschaft | Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel |
| DE102006029445A1 (de) | 2006-06-21 | 2007-12-27 | Bayer Schering Pharma Ag | Neue 3-Cyano-chinoline als Kinase-Inhibitoren |
| DE102006029446A1 (de) * | 2006-06-21 | 2007-12-27 | Bayer Schering Pharma Ag | Neue 3-substituierte-Chinoline als Kinase-Inhibitoren |
| DE102007024470A1 (de) | 2007-05-24 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren |
| EP2072502A1 (de) | 2007-12-20 | 2009-06-24 | Bayer Schering Pharma Aktiengesellschaft | Sulfoximid-substituierte Chinolin- und Chinazolinderivate als Kinase-Inhibitoren |
| WO2011054433A1 (en) | 2009-11-07 | 2011-05-12 | Merck Patent Gmbh | Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| BR112015022417A2 (pt) | 2013-03-14 | 2017-07-18 | Convergene Llc | métodos e composições para inibição de proteínas contendo bromodomínio |
| EP4050005A1 (en) * | 2015-11-25 | 2022-08-31 | Convergene Llc | Bicyclic bet bromodomain inhibitors and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB980394A (en) * | 1962-09-12 | 1965-01-13 | Allen & Hanburys Ltd | Quinaldinium derivatives |
| FR5389M (pt) * | 1966-02-04 | 1967-09-18 | ||
| FR2047882A1 (en) * | 1969-06-20 | 1971-03-19 | Roussel Uclaf | Analgesic antiinflammatory 4-(2-alkoxy - phenylamino-quinolines and intermediates |
| US3919238A (en) * | 1973-06-06 | 1975-11-11 | Morton Norwich Products Inc | 9-(Substituted amino)imidazo(4,5-f) quinolines |
| US3859291A (en) * | 1973-10-01 | 1975-01-07 | Morton Norwich Products Inc | 9-(p-anisidino)-7-methyl-(1h)-pyrazolo(3,4-f)quinoline |
| GB1496371A (en) * | 1975-08-18 | 1977-12-30 | Serdex | 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof |
| EP0187705A3 (en) * | 1985-01-08 | 1988-05-11 | Norwich Eaton Pharmaceuticals, Inc. | Imidazo(4,5-f)quinolines useful as immunomodulating agents |
| US4716168A (en) * | 1985-01-08 | 1987-12-29 | Norwich Eaton Pharmaceuticals, Inc. | Imidazo(4,5-f)quinolines useful as immunomodulating agents |
| IL89029A (en) * | 1988-01-29 | 1993-01-31 | Lilly Co Eli | Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them |
-
1992
- 1992-07-01 CA CA002114727A patent/CA2114727C/en not_active Expired - Fee Related
- 1992-07-01 EP EP92916871A patent/EP0597003A1/en not_active Withdrawn
- 1992-07-01 US US08/190,113 patent/US5506235A/en not_active Expired - Fee Related
- 1992-07-01 JP JP5503553A patent/JPH06504294A/ja active Pending
- 1992-07-01 WO PCT/US1992/005435 patent/WO1993003030A1/en not_active Application Discontinuation
- 1992-07-30 IE IE248592A patent/IE922485A1/en not_active Application Discontinuation
- 1992-07-31 PT PT100751A patent/PT100751A/pt not_active Application Discontinuation
-
1994
- 1994-02-01 FI FI940469A patent/FI940469A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE922485A1 (en) | 1993-02-10 |
| CA2114727C (en) | 1996-12-10 |
| US5506235A (en) | 1996-04-09 |
| PT100751A (pt) | 1993-09-30 |
| JPH06504294A (ja) | 1994-05-19 |
| EP0597003A1 (en) | 1994-05-18 |
| FI940469A (fi) | 1994-02-01 |
| CA2114727A1 (en) | 1993-02-18 |
| WO1993003030A1 (en) | 1993-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI940469A (fi) | Kinoliinijohdannaisia immunostimulantteina | |
| DK0516349T3 (da) | 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister | |
| NO953406D0 (no) | Pyrrolo-pyridinderivater | |
| MX9201823A (es) | Derivados de quinolina. | |
| FI933167A0 (fi) | N-alkylkinuklidiniumsalter som substans-p antagonister | |
| DE69208877D1 (de) | Chinuclidinderivate | |
| NO922182L (no) | Krystallinske oksatiolan-derivater | |
| DK0533268T3 (da) | Benzanilidderivater som 5HT-1D antagonister | |
| FI921182A (fi) | Velangummi som snabbt hydratiseras | |
| DK0606248T3 (da) | Heteroarylaminer som hidtil ukendte acetylcholinesteraseinhibitorer | |
| FI933505A (fi) | Foerfarande foer framstaellning av etenpolymerer med en reducerad halt avkomponenter som kan extraheras med hexan | |
| FI934568A0 (fi) | Hydrofobisitet som aostadkommits med metalljonaktivering | |
| NO960371D0 (no) | Piperazinderivater som ter | |
| DE69132519D1 (de) | Quinolin-Derivate | |
| FI922973A (fi) | Tokoferolblandning foer anvaendning som antioxidant foer krusmyntolja i tuggummi | |
| DK0531548T3 (da) | Carbostyril-forbindelser som anti-thrombotiske midler | |
| FI925763A0 (fi) | Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat | |
| FI925284A (fi) | Inkapslade partiklar anvaendbara som kontrastmedel i kompositioner och metoder, som anvaends vid ultraljud- och roentgenavbildning | |
| NO930520D0 (no) | Bifenyl-substituerte kinolinderivater | |
| NO920420L (no) | 3-quinuklidin-derivater | |
| NO920220L (no) | Sulfonamid-derivater | |
| FI925469A (fi) | Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat | |
| FI923555A (fi) | Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt | |
| FI921666A (fi) | Indolin- och dihydrokinolinfoereningar som oeppnare av kaliumkanal | |
| FI930342A0 (fi) | Pentapeptider som reglerar immun- och nervsystem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |